Many species of genus Salvia (Lamiaceae) are important edible spices and medicinal plants with a long history. In this study, seven undescribed germacrane-type sesquiterpenoids, salsubstolins A-G (1−7), together with four known sesquiterpenoids (8−11), were isolated from the 95% ethanol extract of the whole plants of Salvia substolonifera via bioactivity-guided isolation. Their chemical structures and absolute configurations were confirmed by extensive spectroscopic methods including HRESIMS, IR, NMR, electronic circular dichroism calculations, and single-crystal X-ray diffraction. The anti-Alzheimer’s disease (AD) activity of compounds 1−11 was evaluated using Caernorhabditis elegans AD pathological model. The results showed that both extracts and compound 2 significantly delayed the paralysis of the transgenic C. elegans strain CL4176. Compound 2 was taken as the preferred compound to investigate its molecular mechanism against AD. Further studies showed that 2 significantly reduced the number of Aβ deposition spots and down-regulated the expression of Aβ mRNA. Furthermore, the activation of insulin/insulin-like growth factor signaling-1 (IIS) pathway was observed with daf-16, skn-1 and hsf-1 showing significant upregulation, meanwhile, the expression of vps-34 and bec-1, which are related to autophagy system, were increased. In conclusion, these results suggest that 2 may exert anti-AD effect by inhibiting Aβ deposition through the IIS pathway and autophagy pathway.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: